Effects of Dienogest on Breasts of Women of Reproductive Age: A Cohort Study
OA: green
CC0
AI-generated summary
This cohort study investigated the effects of dienogest on breast tissue in reproductive-aged women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (29)
- A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea via openalex
- Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women via openalex
- Dienogest and the breast via openalex
- Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis via openalex
- Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins via openalex
- Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women via openalex
- Effects of dienogest on breast : MCF cell line data via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study via openalex
- Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy via openalex
- Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells via openalex
- Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? via openalex
- Risk for breast cancer among women with endometriosis via openalex
- Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis via openalex
- Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
- doi:10.2165/00002512-200421130-00004 via openalex
- W1993957286 via openalex
- W1996669267 via openalex
- W2051559140 via openalex
- W2077579184 via openalex
- W2079421112 via openalex
- W2120332483 via openalex
- W2129353515 via openalex
- W2163315477 via openalex
- W2469416225 via openalex
- W2917177127 via openalex
- W1593442063 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK